Steven Cohen's NPCE Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 152,025 shares of NeuroPace, Inc. (NPCE) worth $2 M, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in NPCE, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 127,384 shares. Largest reduction occurred in Q4 2022, reducing 145,703 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's NeuroPace (NPCE) Holding Value Over Time
Track share changes against reported price movement
Quarterly NeuroPace (NPCE) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +127,384 | Add 516.96% | 152,025 | $13.15 |
| Q4 2025 | +24,641 | New Buy | 24,641 | $15.44 |
| Q1 2025 | -32,943 | Sold Out | 0 | $0.00 |
| Q4 2024 | +32,943 | New Buy | 32,943 | $11.19 |
| Q4 2022 | -145,703 | Sold Out | 0 | $0.00 |
| Q3 2022 | -3,496 | Reduce 2.34% | 145,703 | $3.75 |
| Q2 2022 | -59,977 | Reduce 28.67% | 149,199 | $4.95 |
| Q1 2022 | +72,976 | Add 53.58% | 209,176 | $8.21 |
| Q4 2021 | +136,200 | New Buy | 136,200 | $10.08 |
Steven Cohen's NeuroPace Investment FAQs
Steven Cohen first purchased NeuroPace, Inc. (NPCE) in Q4 2021, acquiring 136,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held NeuroPace, Inc. (NPCE) for 9 quarters since Q4 2021.
Steven Cohen's largest addition to NeuroPace, Inc. (NPCE) was in Q4 2021, adding 136,200 shares worth $1.37 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 152,025 shares of NeuroPace, Inc. (NPCE), valued at approximately $2 M.
As of the Q1 2026 filing, NeuroPace, Inc. (NPCE) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in NeuroPace, Inc. (NPCE) was 209,176 shares, as reported at the end of Q1 2022.